Neuroscience
Creative Biolabs Enhances Neuroscience Research with Cutting-Edge Electrophysiology and Electrode Chip Technologies
Creative Biolabs introduces advanced electrophysiology and electrode chip technologies to significantly impact neuroscience research, offering new avenues for understanding neuronal activity and developing neurotherapeutics.
InMed Pharmaceuticals Reports Promising Preclinical Results for Alzheimer's Treatment
InMed Pharmaceuticals Inc. announces positive preclinical results for INM-901, showing potential in reducing neuroinflammation associated with Alzheimer's disease, independent of amyloid beta or tau pathology.
Cure Alzheimer’s Fund Honors Breakthrough Research with Jeffrey L. Morby Prize
The Cure Alzheimer’s Fund has awarded the Jeffrey L. Morby Prize to researchers Andrew S. Yoo and Zhao Sun for their innovative study on modeling late-onset Alzheimer’s disease, marking a significant step forward in understanding and potentially treating the condition.
Brisa Therapeutics Highlights Nature's Impact on Mental Wellness in Podcast Feature
Brisa Therapeutics discusses the therapeutic benefits of nature on mental and emotional health in a recent podcast episode, emphasizing the science behind how natural environments facilitate healing and nervous system regulation.
Clene Inc. CEO to Present at Investor Summit Virtual, Highlighting Progress in Neurodegenerative Disease Treatment
Clene Inc.'s CEO Rob Etherington will update investors on the company's advancements in treating neurodegenerative diseases at the Investor Summit Virtual, showcasing potential breakthroughs in mitochondrial health and neuronal protection.
Cure Alzheimer’s Fund Strengthens Leadership with New Board Appointments
Cure Alzheimer’s Fund enhances its leadership team by appointing Christine Villas-Boas and Brittany Bowlen to its Board of Directors, aiming to accelerate research against Alzheimer’s disease.
Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control
Researchers have engineered a novel chemogenetic tool called RADICAL that enables non-invasive, precise manipulation of brain activity using a synthetic chemical, offering significant potential for neuroscience research and therapeutic interventions.
Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease
A groundbreaking research from Karolinska Institutet suggests a significant biological link between autism spectrum disorder and Parkinson's disease, potentially opening new avenues for understanding neurodegenerative conditions.
Creative Biolabs to Explore Neural Mechanisms of Survival Behaviors in Upcoming Webinar
A pioneering webinar hosted by Creative Biolabs will delve into the complex neural circuits that govern fundamental survival behaviors, offering researchers insights into how organisms perceive danger and make critical decisions.
Annovis Bio Advances Alzheimer's Treatment with Phase 3 Clinical Trial
Annovis Bio has initiated a pivotal Phase 3 clinical trial for buntanetap, a potential treatment for early Alzheimer's disease, with the potential to address symptomatic and disease-modifying aspects of the condition.
Quantum BioPharma Advances Multiple Sclerosis Drug Candidate Through Critical Toxicity Studies
Quantum BioPharma has completed key 90-day toxicity studies for its multiple sclerosis drug candidate Lucid-21-302, positioning the company to file an Investigational New Drug application with the FDA and potentially develop a first-in-class MS therapy.
Research Uncovers Early Development Patterns of Pediatric Brain Tumors
A new study explores the complex origins of medulloblastoma in specialized nerve cells, potentially offering insights for future treatment strategies in pediatric brain cancer.
Clene Inc. to Present at D. Boral Capital Global Conference in New York
Clene Inc., a late clinical-stage biopharmaceutical company developing neurological disease treatments, will participate in the D. Boral Capital Inaugural Global Conference, offering investors an opportunity to learn about its innovative research and potential therapeutics.
Dr. Nupur Ghoshal Receives Alois Alzheimer Award for Groundbreaking Dementia Research
Dr. Nupur Ghoshal, a distinguished neurologist and researcher at Washington University School of Medicine, has been honored with the prestigious Alois Alzheimer Award for her significant contributions to understanding and advancing Alzheimer's and dementia research.
Bone Science Launches Advanced Cellular Health and Brain Enhancement Supplements
Bone Science's introduction of Prime NMN and Prime Brain supplements marks a significant advancement in personalized healthcare, offering solutions for cellular regeneration and cognitive enhancement across different age groups.